Market Overview

Depomed to Present at Healthcare Conferences in February


NEWARK, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) --

Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in fireside chats at the following healthcare conferences during the month of February.

LEERINK Partners 7th Annual Global Healthcare Conference

Date: Wednesday, February 14, 2018
Time: 2:00 p.m. EST
Location: New York, New York

RBC Capital Markets 2018 Global Healthcare Conference

Date: Thursday, February 22, 2018
Time: 11:30 a.m. EST
Location: New York, New York

The fireside chats will be webcast live and may be accessed via the Investor Relations' page of the Depomed website at A recording of these events will be archived for 30 days on the company's website.

About Depomed

Depomed is a leading specialty pharmaceutical company committed to putting the Patient First in everything it does. Depomed is focused on enhancing the lives of patients, families, physicians, providers and payors through the commercialization of products in the areas of pain and neurology, and in the development of drugs in areas of unmet medical need. Depomed currently markets three medicines focused on neuropathic pain and migraine through its Neurology and Pain businesses and its emerging Specialty Business is focused on orphan drug indications and areas of unmet medical need. To learn more about Depomed, visit

Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications

Primary Logo

View Comments and Join the Discussion!